Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Van Herk Groep is a privately held Dutch investment group based in Rotterdam with activities spanning real estate, construction, project development, and investments in biotechnology and life sciences. The group appears to operate primarily as an investment and asset-holding organization rather than as a drug developer, with life sciences exposure conducted through Van Herk Ventures and broader investing through Van Herk Investments. Its public materials emphasize long-term, flexible investing in both listed and unlisted companies, with private-company investing focused mainly on the Benelux and public-equity investing conducted globally. In healthcare, the firm functions as an investor/shareholder rather than an operating biotech or pharmaceutical company. For biotech analysts, the key point is that Van Herk Groep is a cross-sector investment house with meaningful life sciences investing activity, not a therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Van Herk Groep.